Using Marketing Expertise to Propel Timely & Successful Clinical Trials.

According to a new study by pharmaceutical research firm, Best Practices, LLC, targeted clinical communications are important in large-scale Phase III clinical trials to enable the recruitment of the right number and types of patients necessary for timely completion of the trials.

Drawn from in-depth interviews with executives at nine pharmaceutical companies, six contract research organizations and eight study sites, “Best Practices in Clinical Study Communication” maps the operational pathway to clinical communications success, by exploring:

— Effective targeting of patients and study sites

— Expansive recruitment and preparation of study sites

— Optimum patient recruitment and retention

“Competing for clinical investigators has become a critical issue for pharmaceutical companies and contract research organizations,” says Paul Meade, vice president of Best Practices, LLC. “Getting the right message to the right investigator at the right time is the key to success in conducting clinical trials.”

To view report CLICK below:

http://www.benchmarkingreports.com/r/r460.htm